Create personalized user journeys with Omnichannel Marketing as a Service.
Leverage a suite of professional services for pharma and life sciences.
Empower your marketing operations with AI and Data.
Develop and enable adaptable pharma and life sciences marketing content.
Adopt a future-proof holistic approach to content strategy.
Enable format-free marketing with content management platform.
The innovation-powered content management platform to produce and distribute high quality digital content
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
In the pre-digital era, clinical trials relied on traditional methodologies centered around in-person interactions and manual data collection, which presented numerous limitations.
Patient recruitment often required participants to travel to trial sites, like hospitals or research centers, creating barriers due to geographic distance, travel costs, and time away from daily obligations. This restricted participation, limiting accessibility and diversity within trials.
Data collection involved paper forms, diaries, and in-person interviews, which, while essential for documenting symptoms and outcomes, were prone to human error. Accuracy often depended on participants’ memory and consistency, and the manual nature of data management increased risks of loss and mismanagement, complicating trial administration.
On top of that, strict protocols defined every aspect of traditional clinical trials, from participant eligibility to data collection methods. While necessary for regulatory compliance, this rigidity limited flexibility, making it difficult to adapt to unforeseen circumstances or individual needs. The reliance on multiple in-person visits for screening, treatment, and follow-ups extended trial timelines, often leading to participant dropout and reduced engagement.
Traditional trials also faced logistical challenges beyond recruitment and data accuracy. Maintaining regulatory compliance required extensive documentation and oversight, while handling paper-based data was labor-intensive and prone to mismanagement. These cumulative hurdles underscored the need for innovation, paving the way for digital transformation and modernizing clinical research.
Digital transformation is reshaping clinical trials, bringing improvements in speed, accessibility, and data reliability that make the entire process more effective and inclusive.
First of all, tools like wearables and mobile apps allow clinical researchers to collect data in real time directly from trial participants which boosts accuracy and reduces delays. At the same time, AI and ML show potential to further improve the trial process by detecting trends in data.
Digital tools lead to greater engagement by removing geographic barriers and allowing patients to participate from their homes. Improved communication channels also mean that patients can share health data and feedback directly with researchers, creating a more collaborative experience.
Recruitment is also benefitting from this digital shift. Targeted digital outreach through social media and healthcare apps enables trials to identify and recruit eligible participants more efficiently than traditional methods, resulting in a more diverse participant pool.
Altogether, these developments have given rise to digital clinical trials, a model that leverages technology to enhance patient recruitment, retention, data collection, and analytics. This approach is setting a new standard for clinical trials, making them more adaptable and ready for the future of healthcare research.
Source: Digitizing clinical trials, Npj Digital Medicine
The push for digital transformation in clinical research has driven groundbreaking changes in the pharmaceutical industry, with digital tools and generative AI beginning to reshape the clinical trial landscape. In 2023, these advances enabled faster data collection, more efficient processes, and enhanced patient experience, signaling a promising future for patient-centric innovation. However, the path to a fully digitalized clinical research environment remains strewn with complex challenges that pharma organizations must address to ensure sustainable transformation.
The rapid adoption of digital tools, including AI in clinical trials, requires pharmaceutical firms to adapt quickly to a constantly changing landscape. Clinical operations teams face pressure to implement these tools effectively while upholding compliance and quality standards. Adapting to these advancements is challenging, as organizations must ensure these technologies meet regulatory requirements and genuinely enhance clinical trial processes without adding operational complexity.
Budget constraints remain one of the biggest hurdles to sustainable digital transformation in the clinical research setting. Nearly half of senior leaders report difficulties in securing adequate funding for digital initiatives, and most expect their digital transformation budgets to remain flat or decrease in the coming year. This financial strain is particularly problematic as the industry moves away from COVID-19-era digital plans, with some leaders reporting a reduction in digital resources initially allocated to handle the pandemic. Without a consistent and sustainable financial commitment, clinical research teams face the risk of stalled innovation and a limited ability to scale digital advancements.
As digital transformation progresses, data-driven decision-making has become essential for maximizing patient value and streamlining trial processes. Senior leaders recognize the direct link between digital maturity and the value delivered to customers and patients. Yet, there is a shift in focus from broader patient access and inclusion toward enhancing the experience, creating a potential trade-off between inclusive trial access and quality of engagement. This shift underscores a core challenge: achieving a balance between improving patient experience and expanding patient diversity and inclusion, two pillars crucial to the future of clinical research.
More pharmaceutical companies than ever are developing structured digital transformation strategies; however, the timeline for achieving these visions might pose a challenge. 83% of leaders now report having a clear digital transformation strategy, and 80% believe it can be fully realized within five years, while the remainder is less optimistic.
To digitally transform clinical trials, you need a specialized workforce with expertise in emerging technologies. However, less than half of clinical operations leaders report having sufficient training resources for their teams. While companies are actively recruiting digital experts, a lack of comprehensive training for current employees hinders progress, as the success of digital transformation depends heavily on a team’s ability to operate new tools and systems skillfully.
The integration of digital tools in clinical trials is transforming the landscape by enhancing efficiency, improving data quality, and increasing participant engagement. Let’s take a look at how various tools are used in modern digital trials.
Thanks to wearable technology, the world where clinical trials don’t require constant trips to the clinic is much closer. These small devices are transforming research by offering unprecedented ways to collect and analyze data, making trials more efficient and accessible.
Wearables allow clinical trial researchers to track vital health metrics like heart rate, blood pressure, and sleep patterns 24/7, providing a detailed view of participants’ well-being. This continuous monitoring replaces the gaps left by traditional methods that rely on periodic site visits. For example, Pfizer used wearables in an eczema trial to monitor patients’ nighttime scratching habits from home, offering insights without disrupting their daily lives.
The convenience of wearables also opens doors for remote participation. By reducing the need for frequent clinic visits, trials become accessible to people in underserved or remote areas, improving inclusivity. Patients are more engaged too — they can see their progress in real time, fostering adherence to treatment protocols and even encouraging healthier lifestyle choices.
Beyond basic metrics, modern wearables capture diverse data, from glucose levels to stress indicators. This variety enriches analysis, helping clinical trial researchers draw more robust conclusions about treatments. With about 1,932 clinical trials already leveraging wearables, it’s clear this technology is reshaping the future of clinical research — making it smarter, more inclusive, and deeply patient-centered.
Mobile apps are making clinical trials processes easier and more accurate for everyone. In the past, patients had to use paper diaries to track symptoms and medication. This was inconvenient — you had to write things down right away to avoid forgetting, and carrying the diary everywhere was a hassle. Now, with smartphones always in hand, it’s as simple as opening an app, tapping a few buttons, and recording your health updates on the spot.
These mobile health apps go beyond convenience. They let clinical trial researchers see patients’ health by enabling real-time remote monitoring, like tracking heart rate or medication use, without constant clinic visits. They also simplify the informed consent process, allowing participants to sign forms electronically and better understand study details. Apps even send reminders for appointments or medication, helping patients stay on track.
In some cases, mobile technologies make it possible to run entirely virtual trials, removing the need for travel and opening the door for more people to participate.
Telehealth and telemedicine are new-ish approaches to delivering healthcare services remotely, leveraging telecommunications and digital technologies. Their application in clinical trials has grown significantly, particularly in response to the challenges posed by the COVID-19 pandemic.
Telehealth encompasses a broad range of health-related services delivered through electronic means. This includes not only remote clinical services but also educational and administrative functions, such as provider training and patient education. Telemedicine, on the other hand, is often viewed as a subset of telehealth that specifically refers to remote clinical services — diagnosis, treatment, and monitoring of patients without requiring in-person visits. It includes synchronous (real-time) consultations and asynchronous (store-and-forward) methods where patient data is collected and sent for later review by healthcare providers.
One major advantage of telemedicine in clinical trials is its ability to facilitate virtual consultations and follow-ups. For example, participants can connect with researchers through video calls to discuss their progress, report symptoms, or receive guidance without traveling to a trial site. This approach significantly reduces dropout rates by removing logistical hurdles.
Telehealth also streamlines the informed consent process. Instead of attending in-person sessions, participants can review and sign consent forms electronically via secure platforms. Interactive features, such as video explanations and live Q&A sessions, ensure participants fully understand study requirements. This approach speeds up enrollment and increases participation rates, particularly in diverse and hard-to-reach populations.
Moreover, telehealth contributes to cost efficiency in digital clinical trials. By reducing the need for physical trial sites and travel reimbursements, sponsors can allocate resources more effectively. Trials for conditions like rare diseases have particularly benefited, as telemedicine allows global recruitment and monitoring, which would otherwise be prohibitively expensive.
Examples like the use of telehealth in stroke trials, such as TeleStroke, illustrate its potential. It’s a system for acute remote stroke care that has become an essential resource for emergency departments lacking in-house neurology or radiology expertise. It has significantly expanded access to urgent stroke care, benefiting millions of patients. Similarly, oncology trials have adopted telemedicine to facilitate patient-reported outcomes, allowing researchers to better assess the real-world effectiveness of treatments.
EHRs are increasingly utilized in modern digital clinical trials, serving as a valuable tool for enhancing efficiency in recruitment, screening, data collection, and trial design. Their integration into clinical trials is not entirely new, however, their application has evolved significantly with advancements in technology and an increasing emphasis on data-driven approaches in healthcare.
One of the most transformative contributions of EHRs lies in patient identification and recruitment. In the past, finding eligible participants often involved labor-intensive processes and significant delays. With EHRs, clinical trial researchers can swiftly access comprehensive patient data, including demographics, medical history, and treatment records, to pre-screen candidates based on specific eligibility criteria. This streamlined approach has drastically improved recruitment rates, reducing timelines and ensuring that trials move forward with the right participants.
Another area where EHRs excel is in supporting longitudinal follow-up, a critical aspect of understanding long-term treatment effects. By maintaining comprehensive and accessible records of patient health over extended periods, EHRs ensure that even post-trial observations are seamlessly integrated into the research process. This capability is invaluable for assessing the durability and safety of interventions, especially in chronic or complex conditions.
Organizations that want to achieve effective digital clinical trials can adopt several strategic approaches to enhance efficiency, improve data quality, accelerate patient recruitment and increase participant engagement. Here are key strategies based on recent insights.
1. Focus on getting better data to make reality-driven decisionsAdopt tools like EHRs, wearables, and mobile apps for real-time data collection. These technologies ensure faster trials and improve data reliability. Use advanced analytics and AI to identify trends quickly and make data-driven decisions.
2. Use technology to engage with patients during a clinical trialCreate user-friendly mobile apps to help participants track their health and communicate with clinical trial researchers easily. This improves compliance and fosters collaboration. Incorporate telemedicine solutions to provide ongoing support and maintain regular contact with participants.
3. New channels for patient recruitmentUse digital platforms and social media for targeted participant outreach. This speeds up recruitment significantly. Implement virtual consent processes to simplify and expedite enrollment.
4. Promote collaboration across departmentsEncourage open communication between teams like research, regulatory, and data management through shared digital platforms. Regular workshops can ensure alignment and make your digital integration smoother.
5. Work as a team to determine good KPIsWork with stakeholders to define specific measurable KPIs to track the success of digital efforts. Balance quick wins with long-term objectives by identifying areas where immediate improvements can be made while progressing towards broader transformation goals to showcase value (which can lead to better funding).
6. Don’t sleep on talent developmentProvide training to upskill your clinical operations team and close knowledge gaps. Bring in digital experts to lead transformation efforts and promote a culture of innovation.
The current clinical trials infrastructure is fundamentally misaligned with modern medical research needs. As digital health technologies rapidly transform virtually every sector of society, healthcare research remains frustratingly tethered to old-school methodologies.
Emerging digital innovations are challenging this status quo. Advanced personal medical sensors, integrated health record systems, and sophisticated digital communication platforms are gradually infiltrating clinical research, offering glimpses of a more agile, patient-centered approach to scientific investigation. These technologies promise to transcend traditional geographical and logistical constraints that have long limited medical research.
Despite widespread technological disruption across industries, clinical trials have resisted change. However, the pressure to modernize is mounting. The potential to dramatically accelerate drug development, enhance research accessibility, and generate more nuanced, real-world data is compelling leaders to reimagine how medical investigations are conducted.
While implementation challenges persist, the trajectory is clear. Digital methodologies are not just incremental improvements but transformative mechanisms for reshaping how we understand, develop, and validate medical interventions. The future of clinical research lies in embracing these techno
